Hiroshi Yoshida
- Molecular Biology top 2%
- Oncology top 1%
- Surgery top 2%
- Endocrinology, Diabetes and Metabolism top 1%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Akira MiyauchiKanji KumaYasuhiro ItoFumio MatsuzukaKaoru KobayashiAkihiro MiyaNobuyuki AminoTomoyasu Kato
- Topics
- Ovarian cancer diagnosis and treatment (50 papers)Endometrial and Cervical Cancer Treatments (47 papers)Thyroid Cancer Diagnosis and Treatment (46 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshi Yoshida
475 papers receiving 8.1k citations
Peers
Comparison fields: 5 of 181
- Molecular Biology 3.0k
- Oncology 2.1k
- Surgery 1.3k
- Endocrinology, Diabetes and Metabolism 1.2k
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Hiroshi Yoshida
This map shows the geographic impact of Hiroshi Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yoshida more than expected).
Fields of papers citing papers by Hiroshi Yoshida
This network shows the impact of papers produced by Hiroshi Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yoshida. The network helps show where Hiroshi Yoshida may publish in the future.
Co-authorship network of co-authors of Hiroshi Yoshida
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Yoshida. A scholar is included among the top collaborators of Hiroshi Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Yoshida. Hiroshi Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 8 | |
| 10 | 0 | |
| 11 | 4 | |
| 12 | 18 | |
| 13 | 5 | |
| 14 | 51 | |
| 15 | 3 | |
| 16 | 11 | |
| 17 | 2 | |
| 18 | Expression of p8 protein in breast carcinoma; an inverse relationship with apoptosis. | 30 |
| 19 | 1 | |
| 20 | 15 |
About Hiroshi Yoshida
Hiroshi Yoshida is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 506 papers that have together received 8.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (50 papers), Endometrial and Cervical Cancer Treatments (47 papers) and Thyroid Cancer Diagnosis and Treatment (46 papers). The work is most often cited by research in Oncology (2.1k citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Reproductive Medicine (519 citations). Hiroshi Yoshida has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Akira Miyauchi, Kanji Kuma, Yasuhiro Ito, Fumio Matsuzuka, Kaoru Kobayashi, Akihiro Miya, Nobuyuki Amino, Tomoyasu Kato, Toru Takano and Nobuyoshi Hiraoka. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.